Increased risk of sudden sensorineural hearing loss in patients with human immunodeficiency virus aged 18 to 35 years: A population-based cohort study

Charlene Lin, Shih Wei Lin, Shih Feng Weng, Yong-Song Lin

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Importance: No case series or cohort studies to date in the English literature have evaluated sudden sensorineural hearing loss (SSHL) in patients with human immunodeficiency virus (HIV). Objective: To investigate the risk of developing SSHL in patients with HIV. Design and Setting: Retrospective cohort population-based study using data from the Taiwan National Health Insurance Research Database. Participants: In total, 8760 patients with HIV and 43 800 control subjects without HIV were selected from insurance claims between January 1, 2001, and December 31, 2006. Main Outcome Measure: The incidence of SSHL was assessed and determined at the end of 2009. Results: Among patients aged 18 to 35 years, the incidence of SSHL was 2.17-fold higher in the HIV group than in the control group (4.32 vs 1.99 per 10 000 person-years, P= .03). The risk of developing SSHL increased with HIV infection; an adjusted hazard ratio of 2.169 (95% CI, 1.071-4.391) was calculated using a Cox proportional hazards regression model. Among male patients, the incidence of developing SSHL was 2.23-fold higher (95%CI, 1.06-4.69) in the HIV group than in the control group. The incidence of SSHL did not differ significantly between the HIV group and the control group for patients 36 years or older. Conclusion and Relevance: Human immunodeficiency virus infection is significantly associated with an increased risk of developing SSHL in patients aged 18 to 35 years, particularly among male patients.

Original languageEnglish
Pages (from-to)251-255
Number of pages5
JournalJAMA Otolaryngology - Head and Neck Surgery
Volume139
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Sudden Hearing Loss
Sensorineural Hearing Loss
Cohort Studies
HIV
Population
Incidence
Virus Diseases
Control Groups
Literature
National Health Programs
Insurance
Taiwan
Proportional Hazards Models
Outcome Assessment (Health Care)
Databases

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Increased risk of sudden sensorineural hearing loss in patients with human immunodeficiency virus aged 18 to 35 years : A population-based cohort study. / Lin, Charlene; Lin, Shih Wei; Weng, Shih Feng; Lin, Yong-Song.

In: JAMA Otolaryngology - Head and Neck Surgery, Vol. 139, No. 3, 03.2013, p. 251-255.

Research output: Contribution to journalArticle

@article{847506f5b9cf4d999a6a3ee5857da58e,
title = "Increased risk of sudden sensorineural hearing loss in patients with human immunodeficiency virus aged 18 to 35 years: A population-based cohort study",
abstract = "Importance: No case series or cohort studies to date in the English literature have evaluated sudden sensorineural hearing loss (SSHL) in patients with human immunodeficiency virus (HIV). Objective: To investigate the risk of developing SSHL in patients with HIV. Design and Setting: Retrospective cohort population-based study using data from the Taiwan National Health Insurance Research Database. Participants: In total, 8760 patients with HIV and 43 800 control subjects without HIV were selected from insurance claims between January 1, 2001, and December 31, 2006. Main Outcome Measure: The incidence of SSHL was assessed and determined at the end of 2009. Results: Among patients aged 18 to 35 years, the incidence of SSHL was 2.17-fold higher in the HIV group than in the control group (4.32 vs 1.99 per 10 000 person-years, P= .03). The risk of developing SSHL increased with HIV infection; an adjusted hazard ratio of 2.169 (95{\%} CI, 1.071-4.391) was calculated using a Cox proportional hazards regression model. Among male patients, the incidence of developing SSHL was 2.23-fold higher (95{\%}CI, 1.06-4.69) in the HIV group than in the control group. The incidence of SSHL did not differ significantly between the HIV group and the control group for patients 36 years or older. Conclusion and Relevance: Human immunodeficiency virus infection is significantly associated with an increased risk of developing SSHL in patients aged 18 to 35 years, particularly among male patients.",
author = "Charlene Lin and Lin, {Shih Wei} and Weng, {Shih Feng} and Yong-Song Lin",
year = "2013",
month = "3",
doi = "10.1001/jamaoto.2013.1709",
language = "English",
volume = "139",
pages = "251--255",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Increased risk of sudden sensorineural hearing loss in patients with human immunodeficiency virus aged 18 to 35 years

T2 - A population-based cohort study

AU - Lin, Charlene

AU - Lin, Shih Wei

AU - Weng, Shih Feng

AU - Lin, Yong-Song

PY - 2013/3

Y1 - 2013/3

N2 - Importance: No case series or cohort studies to date in the English literature have evaluated sudden sensorineural hearing loss (SSHL) in patients with human immunodeficiency virus (HIV). Objective: To investigate the risk of developing SSHL in patients with HIV. Design and Setting: Retrospective cohort population-based study using data from the Taiwan National Health Insurance Research Database. Participants: In total, 8760 patients with HIV and 43 800 control subjects without HIV were selected from insurance claims between January 1, 2001, and December 31, 2006. Main Outcome Measure: The incidence of SSHL was assessed and determined at the end of 2009. Results: Among patients aged 18 to 35 years, the incidence of SSHL was 2.17-fold higher in the HIV group than in the control group (4.32 vs 1.99 per 10 000 person-years, P= .03). The risk of developing SSHL increased with HIV infection; an adjusted hazard ratio of 2.169 (95% CI, 1.071-4.391) was calculated using a Cox proportional hazards regression model. Among male patients, the incidence of developing SSHL was 2.23-fold higher (95%CI, 1.06-4.69) in the HIV group than in the control group. The incidence of SSHL did not differ significantly between the HIV group and the control group for patients 36 years or older. Conclusion and Relevance: Human immunodeficiency virus infection is significantly associated with an increased risk of developing SSHL in patients aged 18 to 35 years, particularly among male patients.

AB - Importance: No case series or cohort studies to date in the English literature have evaluated sudden sensorineural hearing loss (SSHL) in patients with human immunodeficiency virus (HIV). Objective: To investigate the risk of developing SSHL in patients with HIV. Design and Setting: Retrospective cohort population-based study using data from the Taiwan National Health Insurance Research Database. Participants: In total, 8760 patients with HIV and 43 800 control subjects without HIV were selected from insurance claims between January 1, 2001, and December 31, 2006. Main Outcome Measure: The incidence of SSHL was assessed and determined at the end of 2009. Results: Among patients aged 18 to 35 years, the incidence of SSHL was 2.17-fold higher in the HIV group than in the control group (4.32 vs 1.99 per 10 000 person-years, P= .03). The risk of developing SSHL increased with HIV infection; an adjusted hazard ratio of 2.169 (95% CI, 1.071-4.391) was calculated using a Cox proportional hazards regression model. Among male patients, the incidence of developing SSHL was 2.23-fold higher (95%CI, 1.06-4.69) in the HIV group than in the control group. The incidence of SSHL did not differ significantly between the HIV group and the control group for patients 36 years or older. Conclusion and Relevance: Human immunodeficiency virus infection is significantly associated with an increased risk of developing SSHL in patients aged 18 to 35 years, particularly among male patients.

UR - http://www.scopus.com/inward/record.url?scp=84875839382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875839382&partnerID=8YFLogxK

U2 - 10.1001/jamaoto.2013.1709

DO - 10.1001/jamaoto.2013.1709

M3 - Article

C2 - 23429891

AN - SCOPUS:84875839382

VL - 139

SP - 251

EP - 255

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 3

ER -